ENDLYZ UK LTD

Active London

Research and experimental development on biotechnology

5 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
E

ENDLYZ UK LTD

Research and experimental development on biotechnology

Founded 24 May 2021 Active London, United Kingdom 5 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 10 Jul 2025 Next due 31 Dec 2026 6 months remaining
Confirmation Submitted 2 Jun 2026 Next due 6 Jun 2027 12 months remaining
Net assets £921K £6M 2024 year on year
Total assets £3M £455K 2024 year on year
Total Liabilities £2M £6M 2024 year on year
Charges 1
1 outstanding

Contact & Details

Contact

Registered Address

71 Kingsway London WC2B 6ST United Kingdom

Website

www.example.com

Full company profile for ENDLYZ UK LTD (13414803), an active life sciences and medical technology company based in London, United Kingdom. Incorporated 24 May 2021. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Apr → 31 Mar 2025
Type small
Next accounts 31 Mar 2026
Due by 31 Dec 2026 6 months remaining

Net Assets, Total Assets & Total Liabilities (2021–2024)

Cash in Bank

£918.53k

Decreased by £350.57k (-28%)

Net Assets

£921.22k

Increased by £6.44M (+117%)

Total Liabilities

£1.60M

Decreased by £5.98M (-79%)

Turnover

N/A

Employees

5

Increased by 2 (+67%)

Debt Ratio

63%

Decreased by 304 (-83%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
31 Mar Year End
2024
31 Mar Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

3 Allotments 12,238,345 Shares £12.24m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
26 Mar 20261,850,000£1.85m£1
31 Mar 20253,300,000£3.30m£1
19 Mar 20257,088,345£7.09m£1

Officers

Officers

2 active 1 resigned
Status
Barker, Laurence Daniel PaulDirectorBritishUnited Kingdom5424 May 2021Active
Edwards, Timothy Peter WarrenDirectorBritishUnited Kingdom693 Feb 2022Active

Shareholders

Shareholders (1)

Endlyz Therapeutics, Inc
100.0%
11,388,345

Persons with Significant Control

Persons with Significant Control (0)

0 Active 1 Ceased
Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

1 outstanding

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
2 Jun 2026Confirmation StatementConfirmation statement made on 23 May 2026 with updates
30 Mar 2026CapitalAllotment of shares (GBP 1,323.8345) on 26 Mar 2026
2 Dec 2025MortgageMortgage Create With Deed With Charge Number Charge Creation Date
10 Jul 2025AccountsAnnual accounts made up to 31 Mar 2025
30 May 2025Confirmation StatementConfirmation statement made on 23 May 2025 with updates
2 Jun 2026 Confirmation Statement

Confirmation statement made on 23 May 2026 with updates

30 Mar 2026 Capital

Allotment of shares (GBP 1,323.8345) on 26 Mar 2026

2 Dec 2025 Mortgage

Mortgage Create With Deed With Charge Number Charge Creation Date

10 Jul 2025 Accounts

Annual accounts made up to 31 Mar 2025

30 May 2025 Confirmation Statement

Confirmation statement made on 23 May 2025 with updates

Recent Activity

Latest Activity

Confirmation statement made on 23 May 2026 with updates

6 days ago on 2 Jun 2026

Allotment of shares (GBP 1,323.8345) on 26 Mar 2026

2 months ago on 30 Mar 2026

Mortgage Create With Deed With Charge Number Charge Creation Date

6 months ago on 2 Dec 2025

Annual accounts made up to 31 Mar 2025

11 months ago on 10 Jul 2025

Confirmation statement made on 23 May 2025 with updates

1 years ago on 30 May 2025